Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin B1 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Cyclin B1 in IF, FACS und IP. Er zeigt eine Reaktivität gegenüber Human, Maus und Hamster.
Produktnummer ABIN3026645

Kurzübersicht für Cyclin B1 Antikörper (ABIN3026645)

Target

Alle Cyclin B1 (CCNB1) Antikörper anzeigen
Cyclin B1 (CCNB1)

Reaktivität

  • 204
  • 91
  • 45
  • 24
  • 21
  • 16
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Human, Maus, Hamster

Wirt

  • 168
  • 44
  • 1
Maus

Klonalität

  • 148
  • 65
Monoklonal

Konjugat

  • 113
  • 9
  • 6
  • 6
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Cyclin B1 Antikörper ist unkonjugiert

Applikation

  • 142
  • 76
  • 60
  • 51
  • 45
  • 40
  • 39
  • 31
  • 27
  • 14
  • 11
  • 9
  • 9
  • 9
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunoprecipitation (IP)

Klon

V92-1
  • Produktmerkmale

    This antibody recognizes a protein of 55-62 kDa, identified as Cyclin B1. In mammals, Cyclin B1 associates with inactive p34cdc2, which facilitates phosphorylation of p34cdc2 at amino acids Thr-14 and Tyr-15. This maintains the inactive state until the end of G2-phase. The inactive Cyclin B1-p34cdc2 complex continues to accumulate in the cytoplasm until the completion of DNA synthesis, when Cdc25, a specific protein phosphatase, dephosphorylates amino acids Thr-14 and Tyr-15 of p34cdc2 rendering the complex active at the G2/M boundary. This mitotic kinase complex remains active until the metaphase/anaphase transition when Cyclin B1 is degraded. This degradation process is ubiquitin-dependent and is necessary for the cell to exit mitosis. Cyclin B1-p34cdc2 plays a critical role in G2 to M transition.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    Hamster protein was used as the immunogen for this Cyclin B1 antibody.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the antibody to be titered up or down for optimal performance.\. FACS: 0.5-1 μg/million cells,IF: 1-2 μg/mL,IP: 1-2 μg/500 μg protein--precipitates active Cyclin B1 complexes

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the Cyclin B1 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    Cyclin B1 (CCNB1)

    Andere Bezeichnung

    Cyclin B1

    Hintergrund

    This antibody recognizes a protein of 55-62  kDa, identified as Cyclin B1. In mammals, Cyclin B1 associates with inactive p34cdc2, which facilitates phosphorylation of p34cdc2 at amino acids Thr-14 and Tyr-15. This maintains the inactive state until the end of G2-phase. The inactive Cyclin B1-p34cdc2 complex continues to accumulate in the cytoplasm until the completion of DNA synthesis, when Cdc25, a specific protein phosphatase, dephosphorylates amino acids Thr-14 and Tyr-15 of p34cdc2 rendering the complex active at the G2/M boundary. This mitotic kinase complex remains active until the metaphase/anaphase transition when Cyclin B1 is degraded. This degradation process is ubiquitin-dependent and is necessary for the cell to exit mitosis. Cyclin B1-p34cdc2 plays a critical role in G2 to M transition.

    Gen-ID

    891

    Pathways

    Zellzyklus, AMPK Signaling, Mitotic G1-G1/S Phases, M Phase
Sie sind hier:
Chat with us!